Juno Bio Ltd.

Executive Summary

Juno Bio Ltd. is a UK-based biotechnology company pioneering direct-to-consumer vaginal microbiome testing to address the female reproductive health gap. Founded in 2020, the company offers an at-home test kit that provides personalized reports and coaching, empowering individuals to monitor their vaginal health. Additionally, Juno Bio aggregates anonymized data to fuel research into conditions like bacterial vaginosis and infertility, aiming to improve diagnostic and therapeutic options for women. With a focus on a previously underserved area, Juno Bio leverages consumer engagement and data-driven insights to drive both commercial growth and scientific discovery. The company operates in the rapidly expanding microbiome and women's health markets, positioning itself as a key player in closing the gender health gap through accessible, data-rich solutions.

Upcoming Catalysts (preview)

• Q1 2027Publication of clinical validation study for test accuracy70% success
• Q3 2026Expansion of DTC sales to Europe or US markets60% success
• Q4 2026Strategic partnership or funding announcement for research pipeline50% success